At JP Morgan this year, pharmaphorum Editor in Chief Jonah Comstock spoke with Jeff Fischer, president of Longhorn Vaccines ...

Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with ...

Donald Trump is preparing to impose tariffs on “trillions” of dollars worth of goods next month as he ramps up his global ...

The hires, meant to shore up a division that has not been as tech-forward as leadership would like, have included Morgan ...

A JPMorgan Asset Management-backed investment group has acquired a massive portfolio of single-family rentals across metro Atlanta, the Atlanta Business Chronicle reported. The 709-home deal comes ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for Nucor. This isn't normal. The overall sentiment of ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

J.P. Morgan analyst Matt Boss raised his rating on Norwegian's stock to overweight from neutral, as his $30 price target implied a 51% upside from Friday's close. He reiterated his overweight rating ...

A report by JPMorgan analysts suggests that the recent stock market sell-off hasn't been mainly driven by recession worries ...

In the same investor note, JP Morgan slashed its price target for Tesla shares to a mere $120, representing more than a 50% ...

JP Morgan said Zepto's dark store additions are moderating, which could help the company contain its quick commerce burn in ...

As a risk of shifting consumer spending plagues the travel industry (airfares, hotels, etc.) the value and experience gap the ...